About Embryyo
Embryyo is a Healthcare company based in Pune (India) founded in 2014. Medical devices are designed and produced via RD processes. Its Indian entity Embryyo Technologies Private Limited reported revenue of ₹1.21 Cr. Embryyo offers products and services including Front-end Innovation and Product Realization. Its focus areas include Diversified Medical Devices.
Company details
Embryyo was established in 2014 in Pune, India, as an RD entity in the medical devices sector. Focus is placed on the design and production of innovative devices to address healthcare needs. Operations are centered in India, with emphasis on research-driven development and manufacturing processes. Services encompass prototyping, testing, and regulatory compliance for medical applications, supporting advancements in the field without external partnerships specified.
- Headquarters Pune, India
- SectorsHealthcare
- Phone•••• ••••
- Website embryyo.com
- Social LinkedIn X Facebook
- Legal Name Embryyo Technologies Private Limited
- Date of Incorporation 17 Feb, 2014
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹1.21 Cr
FY 2025 · +233% YoY
- Net Profit₹15.4 Lakh
FY 2025 · 13% margin
- EBITDA₹17.1 Lakh
FY 2025 · 14% margin
- Investors
Associated legal entities of Embryyo
Embryyo operates through Embryyo Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Embryyo Technologies Private Limited CIN U74900PN2014PTC150648 | Active | 17 Feb 2014 | Pune, Maharashtra | ₹1.2 Cr | 2 | View details |
Products & Services of Embryyo
Embryyo offers a comprehensive portfolio of products and services, including Front-end Innovation and Product Realization.
Identifies and selects novel medical device opportunities.
Develops and engineers new medical device concepts.
Funding Insights of Embryyo
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Embryyo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2017 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Embryyo
Embryyo has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Longitude Prize.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Innovation challenges are organized to solve global health issues. | longitudeprize.org | London, United Kingdom |
Investor details for Embryyo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Embryyo Technologies Private Limited (Embryyo)
Embryyo Technologies Private Limited is the primary company behind Embryyo. The board of Embryyo Technologies Private Limited currently have 2 directors; the longest-serving is Nishant Kumar, appointed in 2014. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nishant Kumar DIN 06743284 | Director | 17 Feb 2014 | 12 yrs 8 mo | Embryyo Technologies Private Limited |
| Prateek Jain DIN 07026877 | Director | 24 Nov 2014 | 11 yrs 11 mo | Embryyo Technologies Private Limited |
Financials of Embryyo
Figures of Embryyo Technologies Private Limited, the primary company behind Embryyo, for FY 2025. Revenue was ₹1.21 Cr (+233% year on year). Net profit was ₹15.4 Lakh (13% margin). EBITDA was ₹17.1 Lakh (14% margin). Revenue has grown at a compounded annual rate of +27% over three years and +5% over five years.
- ₹1.21 CrRevenue · FY 2025 · +233% YoY
- ₹15.4 LakhNet profit · 13% margin
- ₹17.1 LakhEBITDA · 14% margin
- ₹1 LakhPaid-up capital
- +27%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Embryyo Technologies Private Limited are on its company page.
Detailed financial statements for Embryyo
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Embryyo
2 dated milestones of Embryyo across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Embryyo is founded.
- Funding First funding round.
Web traffic of Embryyo
The website of Embryyo (embryyo.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 57.6% vs previous month
Websites whose visitors overlap most with Embryyo. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| facebook.com | 100% | 12.1B | #3 | View details | |
mail.google.com | mail.google.com | 100% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Embryyo
Complete news archive for Embryyo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Embryyo
Embryyo was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Embryyo is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
The primary company behind Embryyo, Embryyo Technologies Private Limited, reported revenue of ₹1.21 Cr for FY 2025, up 233% year on year.
Embryyo was established in 2014 in Pune, India, as an RD entity in the medical devices sector. Focus is placed on the design and production of innovative devices to address healthcare needs. Operations are centered in India, with emphasis on research-driven development and manufacturing processes. Services encompass prototyping, testing, and regulatory compliance for medical applications, supporting advancements in the field without external partnerships specified.
Embryyo offers Front-end Innovation and Product Realization.
Embryyo has 1 investor. Key investors include Longitude Prize.
Embryyo operates through Embryyo Technologies Private Limited.
The legal entities of Embryyo currently have 2 directors, including Prateek Jain, Nishant Kumar.